FDA Drug Recalls

Recalls / Class II

Class IID-0161-2016

Product

Xanax (alprazolam) tablets, 0.25 mg, 100-count bottle, Rx only, Distributed by Pharmacia & Upjohn Co. Division of Pfizer Inc, NY, NY 10017, NDC 0009-0029-01

Brand name
Xanax
Generic name
Alprazolam
Active ingredient
Alprazolam
Route
Oral
NDCs
0009-0090, 0009-0029, 0009-0055, 0009-0094
FDA application
NDA018276
Affected lot / code info
Lot # C111054; Exp. 02/16

Why it was recalled

Subpotent Drug

Recalling firm

Firm
Pfizer Inc.
Manufacturer
PHARMACIA & UPJOHN COMPANY LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
235 East 42nd Street, N/A, New York, New York 10017-5703

Distribution

Quantity
21,120 HDPE bottles
Distribution pattern
Nationwide

Timeline

Recall initiated
2015-09-24
FDA classified
2015-10-29
Posted by FDA
2015-11-04
Terminated
2017-05-08
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0161-2016. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.